RCT of metformin to prevent muscle loss during bed rest in older adults
This randomized controlled trial investigated whether metformin could prevent muscle atrophy and insulin resistance in older adults during bed rest. The abstract indicates metformin has shown benefits for insulin sensitivity and muscle preservation in insulin-resistant populations, but this study's specific findings, sample size, and effect sizes are not reported in the available material.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Dec 5, 2025 · Discovered: Sep 15, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- University of Utah
- Published
- Dec 5, 2025
Sources
Primary source
- University of Utah ↗Clinical trial
Source versions
Assessment history
9/23/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.